EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge

Min-Eun Park, Seo-Yong Lee, Rae-Hyung Kim, Mi-Kyeong Ko, Jeong-Nam Park, Kwang-Nyeong Lee, Su-Mi Kim, Joo-Hyung Choi, Su-Hwa You, Byounghan Kim, Jong-Soo Lee, Jong-Hyeon Park

Trials in Vaccinology · 2016 · 5 · 97-104

DOI: 10.1016/j.trivac.2016.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trials in Vaccinology, 2016. Verfasst von Min-Eun Park und 11 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: QIA’s National Animal Disease Research Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccines for foot-and-mouth disease (FMD) generally use oil adjuvants. For better immunization and safety, an adjuvant should be selected only after careful consideration. In this study, we produced vaccines for O, A, and Asia1 serotypes by mixing oil adjuvants, Emulsigen-D (ED), ISA 201, and ISA 206 with and without an aluminum hydroxide (AL) gel and measured their immunogenicity and safety to obtain information regarding critical differences (survival or weight loss) of vaccine quality in mice; the goal of this test was to overcome the difficulties associated with experiments large or medium-sized animals. The groups immunized with the vaccines containing only the oil adjuvants (ED, ISA 201, and ISA 206) had similar or higher levels of neutralizing antibodies and structural protein antibodies for the FMD virus (FMDV) than the groups immunized with the vaccines including the oil adjuvants mixed with the gel. However, in a challenge test using a mouse model, the protection rate showed the highest results in ISA 201 and ISA 206 mixed with AL. The mice immunized with vaccines containing ED showed temporary weight loss in the early postvaccination stages. Cell-mediated immunity was formed relatively strongly in the group vaccinated with vaccines including ISA 201 and ISA 206. We proposed that combinations of these adjuvants represent candidates for future FMD vaccines.

Förderung

  • QIA’s National Animal Disease Research Project

Zitieren

APA

Park, M., Lee, S., Kim, R., Ko, M., Park, J., Lee, K., Kim, S., Choi, J., You, S., Kim, B., Lee, J., & Park, J. (2016). Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge. Trials in Vaccinology, 5, 97-104. https://doi.org/10.1016/j.trivac.2016.04.006

Vancouver

Park M, Lee S, Kim R, Ko M, Park J, Lee K, et al. Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge. Trials in Vaccinology. 2016;5:97-104. doi:10.1016/j.trivac.2016.04.006

BibTeX
@article{Park2016,
  author = {Park, Min-Eun and Lee, Seo-Yong and Kim, Rae-Hyung and Ko, Mi-Kyeong and Park, Jeong-Nam and Lee, Kwang-Nyeong and Kim, Su-Mi and Choi, Joo-Hyung and You, Su-Hwa and Kim, Byounghan and Lee, Jong-Soo and Park, Jong-Hyeon},
  title = {Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge},
  journal = {Trials in Vaccinology},
  year = {2016},
  volume = {5},
  pages = {97--104},
  doi = {10.1016/j.trivac.2016.04.006}
}
Kostenlos starten →